TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer. Tang R, Wang H, Liu J, Song L, et al. Eur J Med Res 2024;29:112.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang R, Wang H, Liu J, Song L, et al. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer. Eur J Med Res 2024;29:112.
PMID: 38336764